Need Help? Call 1­-866-­796-­7386
« back to stock screener

  KNSA stock: Kiniksa Pharmaceuticals Ltd

Current Rating
Strong Sell

Previous Rating

Strong Sell
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$19.73
Market Cap
1.12B
Sector
Health Care
Div. Growth
-
P/E
-
P/B
2.75
P/S
4.55
Dividend %
-
P/CF
65.3
P/FCF
27.0
Op. Cash Flow
42.5K
FCF
0.6
Op. Margin
15.30%
Net Margin
93.00%
ROE
58.50%
ROI
46.00%
ROA
50.10%
EPS Growth
304.90%
Current Ratio
5.2
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Airsculpt Technologies Inc (AIRS) $6.14 - - 339.6M Strong Buy
ATI Physical Therapy Inc (ATIP) $5.58 - - 30.8M Strong Buy
Aytu Biopharma Inc (AYTU) $3.04 - - 14.8M Strong Buy
Bimi International Medical Inc (BIMI) $1.68 - - 6.4M Strong Buy
Brookdale Senior Living, Inc. (BKD) $6.61 - - 779.2M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More